Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 2
1965 1
1968 1
1970 1
1971 2
1972 6
1973 18
1974 15
1975 30
1976 35
1977 29
1978 16
1979 18
1980 20
1981 24
1982 14
1983 22
1984 15
1985 11
1986 15
1987 17
1988 13
1989 9
1990 19
1991 22
1992 5
1993 14
1994 6
1995 12
1996 6
1997 6
1998 13
1999 7
2000 18
2001 8
2002 14
2003 32
2004 40
2005 44
2006 51
2007 71
2008 52
2009 64
2010 92
2011 113
2012 145
2013 135
2014 145
2015 185
2016 225
2017 282
2018 397
2019 587
2020 869
2021 1004
2022 1090
2023 1076
2024 489

Text availability

Article attribute

Article type

Publication date

Search Results

6,740 results

Results by year

Filters applied: . Clear all
Page 1
Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals.
Legare CA, Raup-Konsavage WM, Vrana KE. Legare CA, et al. Pharmacology. 2022;107(3-4):131-149. doi: 10.1159/000521683. Epub 2022 Jan 28. Pharmacology. 2022. PMID: 35093949 Free article. Review.
BACKGROUND: There is a growing interest in the use of cannabis (and its extracts), as well as CBD oil (hemp extracts containing cannabidiol), for therapeutic purposes. While there is reason to believe that cannabinoids may be efficacious for a number of different diseases …
BACKGROUND: There is a growing interest in the use of cannabis (and its extracts), as well as CBD oil (hemp extracts containing cannabidi
Epilepsy and cannabidiol: a guide to treatment.
Arzimanoglou A, Brandl U, Cross JH, Gil-Nagel A, Lagae L, Landmark CJ, Specchio N, Nabbout R, Thiele EA, Gubbay O, The Cannabinoids International Experts Panel; Collaborators. Arzimanoglou A, et al. Epileptic Disord. 2020 Feb 1;22(1):1-14. doi: 10.1684/epd.2020.1141. Epileptic Disord. 2020. PMID: 32096470 Free article. Review.
The growing interest in cannabidiol (CBD), specifically a pure form of CBD, as a treatment for epilepsy, among other conditions, is reflected in recent changes in legislation in some countries. ...
The growing interest in cannabidiol (CBD), specifically a pure form of CBD, as a treatment for epilepsy, among other conditions, is r …
Cannabidiol Adverse Effects and Toxicity.
Huestis MA, Solimini R, Pichini S, Pacifici R, Carlier J, Busardò FP. Huestis MA, et al. Curr Neuropharmacol. 2019;17(10):974-989. doi: 10.2174/1570159X17666190603171901. Curr Neuropharmacol. 2019. PMID: 31161980 Free PMC article. Review.
BACKGROUND: Currently, there is a great interest in the potential medical use of cannabidiol (CBD), a non-intoxicating cannabinoid. Productive pharmacological research on CBD occurred in the 1970s and intensified recently with many discoveries about the endocannabinoid sys …
BACKGROUND: Currently, there is a great interest in the potential medical use of cannabidiol (CBD), a non-intoxicating cannabinoid. P …
Cannabidiol: pharmacology and therapeutic targets.
Britch SC, Babalonis S, Walsh SL. Britch SC, et al. Psychopharmacology (Berl). 2021 Jan;238(1):9-28. doi: 10.1007/s00213-020-05712-8. Epub 2020 Nov 21. Psychopharmacology (Berl). 2021. PMID: 33221931 Free PMC article. Review.
RATIONALE: Cannabidiol (CBD) products lacking regulatory approval are being used to self-treat a myriad of conditions and for their unsubstantiated health benefits. ...
RATIONALE: Cannabidiol (CBD) products lacking regulatory approval are being used to self-treat a myriad of conditions and for their u …
A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD).
Peng J, Fan M, An C, Ni F, Huang W, Luo J. Peng J, et al. Basic Clin Pharmacol Toxicol. 2022 Apr;130(4):439-456. doi: 10.1111/bcpt.13710. Epub 2022 Feb 6. Basic Clin Pharmacol Toxicol. 2022. PMID: 35083862 Free article. Review.
Cannabidiol (CBD) is an abundant non-psychoactive phytocannabinoid in cannabis extracts which has high affinity on a series of receptors, including Type 1 cannabinoid receptor (CB1), Type 2 cannabinoid receptor (CB2), GPR55, transient receptor potential vanilloid (TRPV) an
Cannabidiol (CBD) is an abundant non-psychoactive phytocannabinoid in cannabis extracts which has high affinity on a series of recept
The Polypharmacological Effects of Cannabidiol.
Castillo-Arellano J, Canseco-Alba A, Cutler SJ, León F. Castillo-Arellano J, et al. Molecules. 2023 Apr 6;28(7):3271. doi: 10.3390/molecules28073271. Molecules. 2023. PMID: 37050032 Free PMC article. Review.
Cannabidiol (CBD) is a major phytocannabinoid present in Cannabis sativa (Linneo, 1753). ...
Cannabidiol (CBD) is a major phytocannabinoid present in Cannabis sativa (Linneo, 1753). ...
The role of cannabidiol in aging.
Ni B, Liu Y, Dai M, Zhao J, Liang Y, Yang X, Han B, Jiang M. Ni B, et al. Biomed Pharmacother. 2023 Sep;165:115074. doi: 10.1016/j.biopha.2023.115074. Epub 2023 Jul 6. Biomed Pharmacother. 2023. PMID: 37418976 Free article. Review.
It is of great significance to search for drugs to extend lifespan and healthspan. Cannabidiol (CBD), a natural nontoxic phytocannabinoid, has been regarded as a potential candidate drug for antiaging. ...
It is of great significance to search for drugs to extend lifespan and healthspan. Cannabidiol (CBD), a natural nontoxic phytocannabi …
Scientific Validation of Cannabidiol for Management of Dog and Cat Diseases.
Corsato Alvarenga I, Panickar KS, Hess H, McGrath S. Corsato Alvarenga I, et al. Annu Rev Anim Biosci. 2023 Feb 15;11:227-246. doi: 10.1146/annurev-animal-081122-070236. Annu Rev Anim Biosci. 2023. PMID: 36790884 Free article. Review.
Cannabidiol (CBD) is a non-psychotropic phytocannabinoid of the plant Cannabis sativa L. ...
Cannabidiol (CBD) is a non-psychotropic phytocannabinoid of the plant Cannabis sativa L. ...
Cannabidiol for the treatment of autism spectrum disorder: hope or hype?
Pedrazzi JFC, Ferreira FR, Silva-Amaral D, Lima DA, Hallak JEC, Zuardi AW, Del-Bel EA, Guimarães FS, Costa KCM, Campos AC, Crippa ACS, Crippa JAS. Pedrazzi JFC, et al. Psychopharmacology (Berl). 2022 Sep;239(9):2713-2734. doi: 10.1007/s00213-022-06196-4. Epub 2022 Jul 29. Psychopharmacology (Berl). 2022. PMID: 35904579 Review.
Therefore, there is great interest in exploring the endocannabinoid system, which modulates the activity of other neurotransmitters, has actions in social behavior and seems to be altered in patients with ASD. Thus, cannabidiol (CBD) emerges as a possible strategy for trea …
Therefore, there is great interest in exploring the endocannabinoid system, which modulates the activity of other neurotransmitters, has act …
The antimicrobial potential of cannabidiol.
Blaskovich MAT, Kavanagh AM, Elliott AG, Zhang B, Ramu S, Amado M, Lowe GJ, Hinton AO, Pham DMT, Zuegg J, Beare N, Quach D, Sharp MD, Pogliano J, Rogers AP, Lyras D, Tan L, West NP, Crawford DW, Peterson ML, Callahan M, Thurn M. Blaskovich MAT, et al. Commun Biol. 2021 Jan 19;4(1):7. doi: 10.1038/s42003-020-01530-y. Commun Biol. 2021. PMID: 33469147 Free PMC article.
Multiple mode-of-action studies point to membrane disruption as cannabidiol's primary mechanism. More importantly, we now report for the first time that cannabidiol can selectively kill a subset of Gram-negative bacteria that includes the 'urgent threat' pathogen Ne …
Multiple mode-of-action studies point to membrane disruption as cannabidiol's primary mechanism. More importantly, we now report for …
6,740 results